J. Schildkraut

发表

Neuropsychopharmacology and the Affective Disorders

J. Schildkraut, 1969 .

The catecholamine hypothesis of affective disorders. A review of supporting evidence.

J. Schildkraut, J J Schildkraut, 1967, International journal of psychiatry.

The catecholamine hypothesis of affective disorders: a review of supporting evidence.

J. Schildkraut, J J Schildkraut, 1965, The American journal of psychiatry.

Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.

A. Schatzberg, J. Schildkraut, R. LaBrie, 1978, Archives of general psychiatry.

Determination of urinary normetanephrine and metanephrine by radial-compression liquid chromatography and electrochemical detection.

J. Schildkraut, P. Orsulak, P. Kizuka, 1983, Clinical chemistry.

Mind and Mood in Modern Art I: Miro and "Melancolie"

J. Schildkraut, A. J. Hirshfeld, 1995 .

Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis

J. Schildkraut, J. Orav, S. Minden, 1988, Neurology.

Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects

A. Schatzberg, J. Schildkraut, J. Posener, 1996, Psychoneuroendocrinology.

Desynchronized sleep and MHPG excretion: an inverse correlation.

J. Schildkraut, E. Hartmann, 1973, Brain research.

Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain.

J. Schildkraut, G. Breese, S. Schanberg, 1969, Biochemical pharmacology.

The effects of pentobarbital on the fate of intracisternally administered norepinephrine-H3.

J. Schildkraut, S. Schanberg, I. Kopin, 1967, The Journal of pharmacology and experimental therapeutics.

Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.

J. Mooney, J. Schildkraut, R. Alexander, 1982, Molecular pharmacology.

Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: preliminary data.

J. Mooney, A. Schatzberg, J. Schildkraut, 1985, Journal of psychiatric research.

Changes in norepinephrine output following light therapy for fall/winter seasonal depression

J. Mooney, J. Schildkraut, K. Bloomingdale, 1992, Biological Psychiatry.

Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.

A. Schatzberg, J. Schildkraut, P. Orsulak, 1980, Schizophrenia bulletin.

Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase

J. Mooney, A. Schatzberg, J. Schildkraut, 1988, Biological Psychiatry.

Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain.

J. Schildkraut, S. Roffler-Tarlov, P. Draskoczy, 1973, Biochemical pharmacology.

Psychotic and nonpsychotic depressions: II. platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms

J. Schildkraut, P. Langlais, A. Rothschild, 1987, Psychiatry Research.

Clozapine response and plasma catecholamines and their metabolites

A. Schatzberg, A. Green, J. Schildkraut, 1993, Psychiatry Research.

Platelet MAO activity: relationships to clinical and psychometric variables.

I. Gottesman, J. Schildkraut, P. Orsulak, 1980, Schizophrenia bulletin.

Behavioral Effects of Centrally Administered 6-Hydroxydopamine

Warren C. Stern, J. Schildkraut, E. Hartmann, 1972 .

Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions.

A. Schatzberg, J. Schildkraut, A. Rosenbaum, 1983, The American journal of psychiatry.

Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion.

J. Schildkraut, R. Watson, E. Hartmann, 1972, The American journal of psychiatry.

BIOCHEMICAL DISCRIMINATION OF SUBGROUPS OF DEPRESSIVE DISORDERS BASED ON DIFFERENCES IN CATECHOLAMINE METABOLISM

A. Schatzberg, J. Schildkraut, A. Rosenbaum, 1982 .

Platelet MAO activity and the dexamethasone suppression test in depressed patients.

A. Schatzberg, J. Schildkraut, A. Rothschild, 1983, The American journal of psychiatry.

Catecholamine metabolism during heroin use.

J. Schildkraut, R. Meyer, S. Mirin, 1977, The American journal of psychiatry.

The effects of heroin on catecholamine metabolism in man.

J. Schildkraut, R. Meyer, S. Mirin, 1975, National Institute on Drug Abuse research monograph series.

Toward a Biochemical Classification of Depressive Disorders IX

A. Schatzberg, J. Schildkraut, Benjamin Gerson, 1985, British Journal of Psychiatry.

Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.

D. Greenblatt, D. Sheehan, J. Schildkraut, 1984, Journal of clinical psychopharmacology.

The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression

J. Schildkraut, K. Bloomingdale, J. Gudeman, 1986, Biological Psychiatry.

Learned helplessness and urinary MHPG levels in unipolar depression.

B. Fenton, J. Schildkraut, S. Hauser, 1992, The American journal of psychiatry.

Effect of cortical spreading depression on norepinephrine-H3 metabolism in brain stem

J. Schildkraut, S. Schanberg, I. Kopin, 1968, Experientia.

Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients.

J. Schildkraut, J. Durell, E. Gordon, 1969, Archives of general psychiatry.

Effects of tricyclic antidepressants on the uptake and mabolism of intracisternally administered norepinephrine-H3 in rat brain.

J. Schildkraut, G. Dodge, M. A. Logue, 1969, Journal of psychiatric research.

Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder.

J. Harmatz, J. Biederman, J. Schildkraut, 1984, The American journal of psychiatry.

Urinary mhpg in anorexia nervosa patients with and without a concomitant major depressive disorder.

J. Harmatz, J. Biederman, J. Schildkraut, 1984, Journal of psychiatric research.

Platelet monoamine oxidase activity in psychiatric disorders: the application of a technique for the isolation of free platelet mitochondria from relatively small blood samples.

J. Mooney, J. Schildkraut, P. Orsulak, 1981, Journal of psychiatric research.

Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.

J. Schildkraut, S. H. Frazier, P. Orsulak, 1976, The American journal of psychiatry.

Changes in norepinephrine turnover in rat brain during chronic administration of imipramine and protriptyline: a possible explanation for the delay in onset of clinical antidepressant effects.

J. Schildkraut, A. Winokur, P. Draskoczy, 1971, The American journal of psychiatry.

Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.

A. Schatzberg, J. Schildkraut, P. Orsulak, 1978, Biological psychiatry.

Elevated platelet MAO activity in schizophrenia-related depressive disorders.

A. Schatzberg, J. Schildkraut, P. Orsulak, 1978, The American journal of psychiatry.

The effects of acute and chronic administration of tricyclic antidepressants on MHPG-SO4 in rat brain.

J. Schildkraut, M. Kling, P. Orsulak, 1977, Communications in psychopharmacology.

Effects of Short- and Long-Term Administration of Tricyclic Antidepressants and Lithium on Norepinephrine Turnover in Brain*

A. Schatzberg, J. Schildkraut, M. Kling, 1976, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

Mind and mood in modern art, II: Depressive disorders, spirituality, and early deaths in the abstract expressionist artists of the New York School.

J. Schildkraut, J. Murphy, A. J. Hirshfeld, 1994, The American journal of psychiatry.

Urinary MHPG and clinical symptoms in patients with unipolar depression

J. Schildkraut, J. Samson, S. Mirin, 1994, Psychiatry Research.

Norepinephrine Pools in Rat Brain: Differences in Turnover Rates and Pathways of Metabolism

J. Schildkraut, P. Draskoczy, Pallas Sun Lo, 1971, Science.

Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites.

A. Schatzberg, J. Schildkraut, R. LaBrie, 1978, Archives of general psychiatry.

Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3).

J. Mooney, J. Alpert, J. Hennen, 2008, Journal of psychiatric research.

Guidelines for therapeutic monitoring of tricyclic antidepressant plasma levels.

J. Schildkraut, P. Orsulak, 1979, Therapeutic drug monitoring.

My Father and I

J. Schildkraut, Leo Lania, 1959 .

Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders.

A. Schatzberg, J. Schildkraut, K. Bloomingdale, 1989, Archives of general psychiatry.

7 – Relationship between Psychiatric Diagnostic Groups of Depressive Disorders and MHPG*

J. Schildkraut, 1983 .

Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock.

J. Schildkraut, A. Kuruc, P. Orsulak, 1980, Science.

Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

J. Schildkraut, G. Breese, S. Schanberg, 1968, Biochemical pharmacology.

Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression

T. C. Bond, A. Schatzberg, J. Schildkraut, 1993, Biological Psychiatry.

Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

J. Schildkraut, 1973, The American journal of psychiatry.

Adolf Wölfli: Draftsman, Writer, Poet, Composer

J. Schildkraut, 1998 .

The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain.

J. Schildkraut, S. Schanberg, I. Kopin, 1967, Biochemical pharmacology.

Effects of Tricyclic Antidepressants on Norepinephrine Metabolism: Basic and Clinical Studies

E. Gershon, J. Schildkraut, E. Grab, 1971 .

Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.

J. Schildkraut, G. Breese, S. Schanberg, 1967, The American journal of psychiatry.

Biogenic Amines and Emotion

S. Kety, J. Schildkraut, 1967, Science.

Alpha-methylparatyrosine and sleep in the rat

J. Schildkraut, E. Hartmann, T. J. Bridwell, 2004, Psychopharmacologia.

Tranylcypromine: effects on norepinephrine metabolism in rat brain.

J. Schildkraut, 1970, The American journal of psychiatry.

Toward a biochemical classification of depressive disorders

A. Schatzberg, J. Schildkraut, A. Rosenbaum, 1981, Psychopharmacology.

Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder

A. Green, J. Wojcik, R. Dawson, 2002, Psychiatry Research.

Focal cerebral perfusion defects demonstrated by 99mTc-hexamethylpropyleneamine oxime SPECT in elderly depressed patients

J. Schildkraut, R. Schwartz, B. Holman, 1996, Psychiatry Research: Neuroimaging.

Haloperidol response and plasma catecholamines and their metabolites

C. Waternaux, M. Tsuang, A. Green, 1993, Schizophrenia Research.

Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine.

J. Schildkraut, J. Durell, E. Gordon, 1965, Journal of psychiatric research.

Heterogeneity in anorexia nervosa

J. Harmatz, J. Biederman, J. Schildkraut, 1986, Biological Psychiatry.

The effects of Δ9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain

J. Schildkraut, D. H. Efron, 2004, Psychopharmacologia.

Antidepressants and Related Drugs

E. Gershon, J. Schildkraut, 1971 .

Norepinephrine metabolism after short- and long-term administration of tricyclic antidepressant drugs and electroconvulsive shock.

J. Schildkraut, 1975, Advances in biochemical psychopharmacology.

Norepinephrine Turnover and Metabolism in Rat Brain after Long-Term Administration of Imipramine

J. Schildkraut, A. Winokur, C. W. Applegate, 1970, Science.

EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID (VMA) IN DEPRESSED PATIENTS TREATED WITH ANTIDEPRESSANT DRUGS.

G. Klerman, R. Hammond, J. Schildkraut, 1964, Journal of psychiatric research.

CLINICAL EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION.

G. Klerman, J. Schildkraut, M. Greenblatt, 1963, Journal of psychiatric research.

BIOCHEMICAL AND PRESSOR EFFECTS OF ORAL d, l‐DIHYDROXYPHENYLALANINE IN PATIENTS PRETREATED WITH ANTIDEPRESSANT DRUGS *

G. Klerman, J. Schildkraut, M. Greenblatt, 1963, Annals of the New York Academy of Sciences.

Clozapine reduces alcohol drinking in Syrian golden hamsters

A. Green, R. Dawson, J. Schildkraut, 2004, Psychiatry Research.

The effects of lithium ion on H3-norepinephrine metabolism in brain.

J. Schildkraut, S. Schanberg, I. Kopin, 1966, Life sciences.

Catecholamine metabolism in affective disorders—III

J. Schildkraut, L. Baer, J. Durell, 1970 .

Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline.

E. Gershon, J. Schildkraut, E. Grab, 1972, Journal of psychiatric research.

Pharmacology—The Effects of Lithium on Biogenic Amines

J. Schildkraut, 1973 .

Platelet monoamine oxidase activity and deficit syndrome schizophrenia

J. Schildkraut, R. Gurrera, J. Samson, 1995, Psychiatry Research.

Platelet monoamine oxidase activity schizophrenia and deficit syndrome

J. Schildkraut, R. Gurrera, J. Samson, 1995 .

Normetanephrine excretion and affective state in depressed patients treated with imipramine.

J. Schildkraut, J. Durell, R. Green, 1966, The American journal of psychiatry.

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

A. Green, J. Schildkraut, R. Strous, 1999, Harvard review of psychiatry.

THE EFFECTS OF LITHIUM ON NOREPINEPHRINE TURNOVER AND METABOLISM: BASIC AND CLINICAL STUDIES

J. Schildkraut, 1974, The Journal of nervous and mental disease.

Should Clozapine Be a First‐line Treatment for Schizophrenia? The Rationale for a Double‐Blind Clinical Trial in First‐Episode Patients

A. Green, J. Schildkraut, 1995, Harvard review of psychiatry.

Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.

A. Schatzberg, J. Schildkraut, J. Samson, 1982, The American journal of psychiatry.

Comparative properties of soluble and particulate catechol-O-methyl transferases from rat red blood cells: preliminary observations.

J. Schildkraut, P. Orsulak, T. Reigle, 1974, Advances in biochemical psychopharmacology.

Norepinephrine Metabolism in Depressive Disorders: Implications for a Biochemical Classification of Depressions

A. Schatzberg, J. Schildkraut, R. LaBrie, 1978 .

The dexamethasone suppression test: An overview of its current status in psychiatry

G. Klerman, R. Baldessarini, B. Carroll, 1987 .

Clinical utility of tricyclic antidepressant blood levels: a case report.

P. Appelbaum, J. Schildkraut, P. Orsulak, 1979, American Journal of Psychiatry.

Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study.

J. Mooney, J. Alpert, J. Schildkraut, 2013, Journal of psychiatric research.

Beyond Reason: Art and Psychosis: Works From the Prinzhorn Collection

J. Schildkraut, 2000 .

Madness and Art: The Life and Works of Adolf Wölfli

J. Schildkraut, A. J. Hirshfeld, 1995 .

Rembrandt by Himself

J. Schildkraut, 1999, American Journal of Psychiatry.

Saint Jerome in a dark chamber: Rembrandt's metaphoric portrayal of the depressed mind.

J. Schildkraut, 2004, The American journal of psychiatry.

Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions.

A. Schatzberg, J. Schildkraut, A. Rosenbaum, 1982, The American journal of psychiatry.

Hypothalamic–pituitary–adrenal axis effects on plasma homovanillic acid in man

A. Schatzberg, J. Schildkraut, J. Posener, 1999, Biological Psychiatry.

Amitriptyline in the Treatment of Anorexia Nervosa: A Double‐Blind, Placebo‐Controlled Study

J S Harmatz, J. Rosenbaum, J. Harmatz, 1985, Journal of clinical psychopharmacology.

M.H.P.G. excretion and clinical classification in depressive disorders.

J. Schildkraut, E. Hartmann, E. Grab, 1973, Lancet.

Eminent Creativity, Everyday Creativity, and Health

J. Schildkraut, Alissa Hirshfeld-Flores, 1999, American Journal of Psychiatry.

Opiates, catecholamines, behavior, and mood

J. Schildkraut, T. Babor, R. Meyer, 1978, Psychopharmacology.

The Effects of Unblocked Heroin upon Catecholamine Metabolism Preliminary Findings

J. Schildkraut, R. Meyer, S. Mirin, 1979 .

Alterations in brain norepinephrine metabolism and behavior induced by environmental stimuli previously paired with inescapable shock

J. Schildkraut, A. Kuruc, P. Orsulak, 1981, Behavioural Brain Research.

Effects of 6-Hydroxydopamine on Sleep in the Rat

J. Schildkraut, E. Hartmann, P. Draskoczy, 1971, Nature.

The effects of acute and chronic administration of morphine on norepinephrine turnover in rat brain regions.

J. Schildkraut, M. Roffman, G. Cassens, 1977, Biochemical pharmacology.

The effects of lithium salts on the turnover and metabolism of norepinephrine in rat brain

J. Schildkraut, G. Dodge, M. A. Logue, 2004, Psychopharmacologia.

Amphetamine withdrawal: depression and M.H.P.G. excretion.

J. Schildkraut, R. Watson, E. Hartmann, 1971, Lancet.

Further studies of the effects of morphine on the levels of MHPG-SO4 in rat brain

J. Schildkraut, P. Orsulak, T. Reigle, 1979, Neuropharmacology.

MHPG Excretion in Depressive Disorders: Relation to Clinical Subtypes and Desynchronized Sleep

J. Schildkraut, E. Hartmann, B. A. Keeler, 1973, Science.

Effects of the d- and l-isomers of amphetamine on the levels of 3-methoxy-4-hydroxyphenylglycol sulfate in whole rat brain and rat brain regions.

J. Schildkraut, M. Roffman, G. Cassens, 1978, Biochemical Pharmacology.

Acute and delayed effects of adrenocorticotropic hormone on dopamine activity in man

A. Schatzberg, J. Schildkraut, J. Posener, 1994 .

Neuropharmacology of the affective disorders.

J. Schildkraut, 1973, Annual review of pharmacology.

Biochemical Criteria for Classifying Depressive Disorders and Predicting Responses to Pharmacotherapy: Preliminary Findings from Studies of Norepinephrine Metabolism

J. Schildkraut, 1974, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man

A. Schatzberg, J. Schildkraut, J. Posener, 1994, Biological Psychiatry.

Cortisol feedback effects on plasma corticotropin levels in healthy subjects

A. Schatzberg, J. Schildkraut, J. Posener, 1997, Psychoneuroendocrinology.

Circadian rhythms ofMacaca mulatta: Sleep, EEG, body and eye movement, and temperature

Franz Halberg, Daniel F. Kripke, D. Kripke, 1972, Primates.

CATECHOLAMINE METABOLISM AND AFFECTIVE DISORDERS: STUDIES OF MHPG EXCRETION

J. Schildkraut, 1974 .

Abnormal flash visual evoked response in melancholia: A replication study

F. Duffy, J. Mooney, J. Schildkraut, 1992, Biological Psychiatry.

Abnormal visual evoked response in melancholia

F. Duffy, J. Mooney, J. Schildkraut, 1989, Biological Psychiatry.

Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions.

A. Schatzberg, J. Schildkraut, J. Samson, 1985, Journal of psychiatric research.

Catecholamines in affective disorders.

J. Schildkraut, 1975, Psychopharmacology bulletin.

BIOCHEMICAL DISCRIMINATION OF SUBTYPES OF DEPRESSIVE DISORDERS

A. Schatzberg, J. Schildkraut, R. LaBrie, 1979 .

Biogenic amines and affective disorders.

J. Schildkraut, 1974, Annual review of medicine.

Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate.

J. Schildkraut, L. Baer, J. Durell, 1970, Journal of psychiatric research.

MHPG as a predictor of antidepressant response to imipramine and maprotiline.

A. Schatzberg, J. Schildkraut, A. Rosenbaum, 1980, The American journal of psychiatry.

An improved method for the recovery of mitochondrial monoamine oxidase from human platelets using colchicine and nitrogen decompression.

J. Mooney, J. Schildkraut, P. Orsulak, 1981, Biochemical medicine.

Affective disorders and norepinephrine pharmacology.

J. Schildkraut, S. Schanberg, I. Kopin, 1969, International psychiatry clinics.

Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone

J. Schildkraut, N. Plotnikoff, T. Reigle, 1974, Psychopharmacologia.

Alpha-methylparatyrosine and sleep in the rat

J. Schildkraut, E. Hartmann, T. J. Bridwell, 2004, Psychopharmacologia.

531 Effects of clozapine on cognitive functions in treatment-refractory schizophrenia

A. Green, L. Seidman, J. Patel, 1997, Schizophrenia Research.

The effects of tranylcypromine isomers on norepinephrine-H3 metabolism in rat brain

J. Schildkraut, P. Orsulak, T. Reigle, 2004, Psychopharmacology.

3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid.

J. Schildkraut, G. Breese, S. Schanberg, 1968 .

Norepinephrine Metabolism and Psychoactive Drugs in the Endogenous Depressions

J. Schildkraut, S. Schanberg, I. Kopin, 1968, Pharmacopsychiatry.

Noradrenergic activity during the transition from depression to mania.

J. Schildkraut, J. Schildkraut, Jack Durell, 1971, Lancet.

Neuropsychopharmacology and the affective disorders. (First of three parts).

J. Schildkraut, 1969, The New England journal of medicine.

Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis.

J. Mooney, J. Schildkraut, 2004, The American journal of psychiatry.

Neuropsychopharmacology and the affective disorders. (Third of three parts)

J. Schildkraut, 1969, The New England journal of medicine.

Carnival of the Harlequin

J. Schildkraut, James C O Harris, J. Miró, 2016 .

Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.

J. Mooney, A. Schatzberg, J. Schildkraut, 1991, Journal of clinical psychopharmacology.

The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment.

J. Schildkraut, 1974, Psychopharmacology bulletin.

Turnover and metabolism of norepinephrine in rat brain after 72 hours on a D-deprivation island

J. Schildkraut, E. Hartmann, 2004, Psychopharmacologia.

Toward a biochemical classification of depressive disorders IV: Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine.

A. Schatzberg, J. Schildkraut, A. Rosenbaum, 1980, Communications in psychopharmacology.